- Resources
- Position Papers
Position Papers
EAACI position papers formulate recommendations and aim to provide practical information that can assist clinicians in planning and carrying out investigations on a variety of topics regarding allergy, asthma and clinical immunology. These are the output of our EAACI Task Forces, Sections, Interest Groups and Working Groups. Discover a regularly updated selection of them here!
All Position Papers
Filter
What are you looking for?
-
Category
-
Year
-
Keywords
-
Author
-
Position Paper 20/01/2023
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis
- Gevaert, P.
- Bachert, C.
- et al
-
Position Paper 01/01/2023
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper
- Vazquez-Ortiz, M.
- Alviani, C.
- et al
-
Position Paper 01/11/2022
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy
- Vitte, J.
- Malinovschi, A.
- et al
-
Position Paper 01/11/2022
Role of dietary fiber in promoting immune health – An EAACI position paper
- Venter, C.
- Greenhawt, M.
- et al
-
Position Paper 01/10/2022
Omics technologies in allergy and asthma research: An EAACI position paper
- Radzikowska, U.
- Baerenfaller, K.
- et al
-
Position Paper 01/10/2022
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paper
- Price, O.J.
- Bonini, M.
- et al
-
Position Paper 01/09/2022
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practice
- Ryan, D.
- Clark, E.
- et al
-
Position Paper 01/09/2022
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper
- Bergmann, C.
- Agache, I.
- et al
-
Position Paper 01/08/2022
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paper
- Barbaud, A.
- Arcolaci, A.
- et al
-
Position Paper 01/08/2022
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
- Jutel, M.
- Palomares, O.
- et al
-
Position Paper 01/08/2022
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19
- Sokolowska, M.
- Diamant, Z.
- et al
-
Position Paper 01/07/2022
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper
- Fieten, K.B.
- Cogo, A.
- et al
-
Position Paper 01/07/2022
Cannabis – related allergies: an international overview and consensus recommendations
- Skypala, I.J.
- Brucker, H.
- et al
-
Position Paper 01/06/2022
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities
- Agache, I.
- Antolin-Amerigo, D.
- et al
-
Position Paper 01/06/2022
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
- Zuberbier, T.
- Aberer, W.
- et al
-
Position Paper 01/04/2022
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey
- Khaleva, E.
- Dunn Galvin, A.
- et al
-
Position Paper 01/02/2022
Hypersensitivity reactions to chemotherapy: an EAACI position paper
- Pagani, M.
- Alvarez-Cuesta, E.
- et al
-
Position Paper 01/02/2022
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy
- Cabrera, M.
- Angier, E.
- et al
-
Position Paper 01/01/2022
Hypersensitivity reactions to biological agents: An EAACI position paper
- Bavbek, S.
- Alvarez-Cuesta, E.
- et al
-
Position Paper 01/01/2022
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2
- Korath, A.D.J.
- Janda, J.
- et al
-
Position Paper 01/12/2021
Adherence to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist in articles published in EAACI Journals: A bibliographic study
- Wiehn, E.
- Alvarez-Perea, A.
- et al
-
Position Paper 01/12/2021
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report
- Pfaar, O.
- Bergmann, C.
- et al
-
Position Paper 01/11/2021
Health effects of exposure to chlorination by – products in swimming pools
- Couto, M.
- Bernard, A.
- et al
-
Position Paper 01/11/2021
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseases
- Tramper-Stranders, G.
- Ambrożej, D.
- et al
-
Position Paper 01/10/2021
Management of anaphylaxis due to COVID-19 vaccines in the elderly
- Bousquet, J.
- Agache, I.
- et al
-
Position Paper 01/09/2021
Allergen immunotherapy: The growing role of observational and randomized trial “Real-World Evidence”
- Paoletti, G.
- di Bona, D.
- et al
-
Position Paper 01/08/2021
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
- Hagemann, J.
- Jutel, M.
- et al
-
Position Paper 01/06/2021
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position Paper
- Klimek, L.
- Akdis, C.A.
- et al
-
Position Paper 01/06/2021
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
- Sokolowska, M.
- Eiwegger, T.
- et al
-
Position Paper 01/05/2021
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity
- Torres, M.J.
- Böhm, I.
- et al
-
Position Paper 01/04/2021
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases
- Baumann, R.
- Untersmayr, E.
- et al
-
Position Paper 01/03/2021
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper
- Klimek, L.
- Bousquet, J.
- et al
-
Position Paper 01/03/2021
Placebo effects in allergen immunotherapy – An EAACI Task Force Position Paper
- Pfaar, O.
- Agache, I.
- et al
-
Position Paper 01/03/2021
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ ARIA Position Paper
- Pfaar, O.
- Jutel, M.
- et al
-
Position Paper 01/03/2021
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
- Bousquet, J.
- Akdis, C.A.
- et al
-
Position Paper 01/01/2021
Biologicals in atopic disease in pregnancy: An EAACI position paper
- Pfaller, B.
- Agache, I.
- et al
-
Position Paper 01/11/2020
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement
- Vultaggio, A.
- Agache, I.
- et al
-
Position Paper 01/06/2019
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity
- Brockow, K.
- Ardern-Jones, M.R.
- et al